Mitigation of Malaria in Sub-Saharan Africa through Vaccination: A Budding Road Map for Global Malaria Eradication.

IF 1.5 Q3 HEALTH CARE SCIENCES & SERVICES
Esther Ugo Alum, Christine Ainebyoona, Chinedu Ogbonnia Egwu, Hope Onohuean, Okechukwu Paul-Chima Ugwu, Daniel Ejim Uti, Benedict Nnachi Alum, Darlington Arinze Echegu
{"title":"Mitigation of Malaria in Sub-Saharan Africa through Vaccination: A Budding Road Map for Global Malaria Eradication.","authors":"Esther Ugo Alum, Christine Ainebyoona, Chinedu Ogbonnia Egwu, Hope Onohuean, Okechukwu Paul-Chima Ugwu, Daniel Ejim Uti, Benedict Nnachi Alum, Darlington Arinze Echegu","doi":"10.4314/ejhs.v35i3.9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Malaria remains a major public health and economic burden globally, with sub-Saharan Africa (SSA) accounting for over 90% of cases and deaths. Children under five and pregnant women are the most vulnerable. Resistance to artemisinin-based therapies and insecticides has compounded the challenge. This review evaluates malaria mitigation strategies, emphasizing the potential of vaccination, particularly RTS,S/AS01, as a cornerstone for malaria eradication and achievement of Sustainable Development Goal 3 (SDG 3).</p><p><strong>Methods: </strong>A narrative review approach was adopted. Peer-reviewed literature from 2014 to 2024 was sourced from credible scientific databases, including PubMed, Google Scholar, and ScienceDirect. Selection prioritized studies on malaria control strategies, vaccine trials, efficacy data, implementation frameworks, and health system challenges specific to SSA. The review critically analyzed vaccine trials, community perceptions, and logistical concerns while incorporating the authors' expert perspective.</p><p><strong>Results: </strong>The RTS,S/AS01 vaccine demonstrated moderate efficacy (30-55%) in preventing malaria in children under five in Ghana, Kenya, and Malawi. Other candidates such as R21/Matrix-M showed up to 77% efficacy in trials. Implementation challenges include limited funding, vaccine hesitancy, poor healthcare infrastructure, and community misconceptions. However, integration with routine immunization, enhanced community engagement, and increased investment in health systems significantly improve vaccine acceptance and impact.</p><p><strong>Conclusion: </strong>Vaccination represents a promising, cost-effective, and scalable strategy for malaria eradication in SSA. Strengthening healthcare infrastructure, amplifying vaccine acceptance campaigns, and increasing funding for research and vaccine production are pivotal. Malaria vaccination offers a practical and sustainable pathway toward global malaria elimination and the realization of SDG 3 by 2030.</p>","PeriodicalId":12003,"journal":{"name":"Ethiopian Journal of Health Sciences","volume":"35 3","pages":"205-217"},"PeriodicalIF":1.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287706/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethiopian Journal of Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/ejhs.v35i3.9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Malaria remains a major public health and economic burden globally, with sub-Saharan Africa (SSA) accounting for over 90% of cases and deaths. Children under five and pregnant women are the most vulnerable. Resistance to artemisinin-based therapies and insecticides has compounded the challenge. This review evaluates malaria mitigation strategies, emphasizing the potential of vaccination, particularly RTS,S/AS01, as a cornerstone for malaria eradication and achievement of Sustainable Development Goal 3 (SDG 3).

Methods: A narrative review approach was adopted. Peer-reviewed literature from 2014 to 2024 was sourced from credible scientific databases, including PubMed, Google Scholar, and ScienceDirect. Selection prioritized studies on malaria control strategies, vaccine trials, efficacy data, implementation frameworks, and health system challenges specific to SSA. The review critically analyzed vaccine trials, community perceptions, and logistical concerns while incorporating the authors' expert perspective.

Results: The RTS,S/AS01 vaccine demonstrated moderate efficacy (30-55%) in preventing malaria in children under five in Ghana, Kenya, and Malawi. Other candidates such as R21/Matrix-M showed up to 77% efficacy in trials. Implementation challenges include limited funding, vaccine hesitancy, poor healthcare infrastructure, and community misconceptions. However, integration with routine immunization, enhanced community engagement, and increased investment in health systems significantly improve vaccine acceptance and impact.

Conclusion: Vaccination represents a promising, cost-effective, and scalable strategy for malaria eradication in SSA. Strengthening healthcare infrastructure, amplifying vaccine acceptance campaigns, and increasing funding for research and vaccine production are pivotal. Malaria vaccination offers a practical and sustainable pathway toward global malaria elimination and the realization of SDG 3 by 2030.

通过疫苗接种减轻撒哈拉以南非洲的疟疾:全球消灭疟疾的初步路线图。
背景:疟疾仍然是全球主要的公共卫生和经济负担,撒哈拉以南非洲(SSA)占病例和死亡的90%以上。五岁以下儿童和孕妇是最脆弱的。对以青蒿素为基础的疗法和杀虫剂的耐药性加剧了这一挑战。本综述评估了疟疾缓解战略,强调疫苗接种的潜力,特别是RTS,S/AS01,作为消灭疟疾和实现可持续发展目标3 (SDG 3)的基石。方法:采用叙事回顾法。2014年至2024年的同行评议文献来自可信的科学数据库,包括PubMed、b谷歌Scholar和ScienceDirect。选择疟疾控制战略、疫苗试验、疗效数据、实施框架和SSA特有的卫生系统挑战方面的优先研究。这篇综述在纳入作者的专家观点的同时,批判性地分析了疫苗试验、社区观念和后勤问题。结果:RTS,S/AS01疫苗对加纳、肯尼亚和马拉维五岁以下儿童的疟疾预防效果中等(30-55%)。其他候选药物如R21/Matrix-M在试验中显示出高达77%的疗效。实施方面的挑战包括资金有限、疫苗犹豫、卫生保健基础设施差以及社区误解。然而,与常规免疫相结合、加强社区参与以及增加对卫生系统的投资可显著提高疫苗的接受程度和影响。结论:疫苗接种是一种有希望的、具有成本效益的、可扩展的SSA疟疾根除策略。加强卫生保健基础设施、扩大疫苗接受运动以及增加研究和疫苗生产资金至关重要。疟疾疫苗接种为到2030年全球消除疟疾和实现可持续发展目标3提供了一条切实可行的可持续途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ethiopian Journal of Health Sciences
Ethiopian Journal of Health Sciences HEALTH CARE SCIENCES & SERVICES-
CiteScore
2.10
自引率
8.30%
发文量
137
审稿时长
12 weeks
期刊介绍: Ethiopian Journal of Health Sciences is a general health science journal addressing clinical medicine, public health and biomedical sciences. Rarely, it covers veterinary medicine
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信